Updates in Heart Failure 2025
December 15th-16th 2025
DAY 1 – 15 December 2025
12.00-13.00
Lunch
13.00-13.05
- 13.00-13.05 | Greetings and introduction to the congress
Gianluigi Savarese (Sweden)
Session 1: Translating guidelines into practice: Status of, barriers to and strategies to foster GDMT implementation
Chairs: Camilla Hage (Sweden), Robin Hofmann (Sweden) & Riccardo M. Inciardi (Italy)
13.05-14.55
- 13.05-13.15 | The gap between what guidelines say and what physicians do: The status of GDMT implementation worldwide
Felix Lindberg (Sweden) - 13.15-13.25 | Breaking down barriers: The point of view of the nephrologist on worsening renal function during GDMT
James Burton (United Kingdom) - 13.25-13.35 | Breaking down barriers: Hyperkalemia – are we reaching a consensus for its management?
Gianluigi Savarese (Sweden) - 13.35-13.45 | Breaking down barriers: Hypotension – when is it a real barrier?
Nicolas Girerd (France) - 13.45-13.55 | How to secure a fast and safe initiation of GDMT in clinical practice
Alexandre Mebazaa (France) - 13.55-14.05 | Worsening HF – which are the available weapons?
Marco Metra (Italy) - 14.05-14.15 | Is there any new GDMT to introduce? Challenging the DIGIT-HF and VICTOR trials
Javed Butler (USA) - 14.15-14.55 | Round Table: Ask the experts
All
14.55-15-10
Coffee Break
Session 2: Treating cardio-renal-metabolic disease
Chairs: James Burton (United Kingdom), Francesco Cosentino (Sweden), Lars H. Lund (Sweden)
Discussant: Raffaele Scorza (Sweden)
15.10-16.30
- 15.10-15.20 | CRM: The sizes of the problem
Christian Basile (Sweden) - 15.20-15.30 | Mineralocorticoid receptor: An old and new target for treating CRM
Biykem Bozkurt (USA) - 15.30-15.40 | SGLT2i: Targeting T2DM, HF and CKD
Javed Butler (USA) - 15.40-15.50 | GLP1Ra: Targeting T2DM, CKD, obesity and HFpEF
Mark Petrie (United Kingdom) - 15.50-16.30 | Round Table: Ask the experts
All
16.30-16.50
Coffee Break
Session 3: Iron deficiency in HF
Chairs: Carin Corovic-Cabrera (Sweden), Maurizio Volterrani (Italy)
Discussant: Felix Lindberg (Sweden)
16.50-17.50
- 16.50-17.00 | Iron deficiency in HF: A summary of evidence until 2024
Shelley Zieroth (Canada)
- 17.10-17.20 | Any role for treating iron deficiency in HFpEF
Stephan von Heahling (Germany)
- 17.20-17.30 | What is coming next
John Cleland (United Kingdom)
- 17.30-17.50 | Round Table: Ask the experts
All
- 17.50-18.00 | Closure of the day
Gianluigi Savarese (Sweden)
DAY 2 (morning) – 16 December 2025
- 08.25-08.30 | Greetings
Gianluigi Savarese (Sweden)
Session 4: Cardiac amyloidosis
08.30-09.30
Chairs: Carmen Basic (Sweden) & Krister Lindmark (Sweden)
Discussants: Per Eldhagen (Sweden) & Riccardo M. Inciardi (Italy)
- 08.30-08.40 | How to recognize a patient with cardiac amyloidosis
Davide Stolfo (Italy) - 08.40-08.50 | Advances in treatment: current and upcoming therapeutic options
Peter van der Meer (The Netherlands) - 08.50-09:00 | Cardiac amyloidosis in clinical practice: Case-based discussion
Antonio Cannata (United Kingdom) - 09.00-09:30 | Round Table: Ask the experts
All
- 09.30-09.55 | Lecture 1: Increasing patient adherence and addressing polypharmacy in patients with HF
Chair: Gianluigi Savarese (Sweden), Speaker: Giuseppe Rosano (United Kingdom)
09.55-10.15
Coffee Break
Session 5: Not only pharmacological treatments: Devices!
Chairs: Andreas Rück (Sweden) & Shelley Zieroth (Canada)
Discussant: Elmir Omerovic (Sweden)
10.15-11.45
- 10.15-10.25 | Primary prophylactic ICD in HF: Towards precision medicine
Frieder Braunschweig (Sweden) - 10.25-10.35 | CRT: When is OMT and time to proceed with implantation?
Wilfried Mullens (Belgium) - 10.35-10.45 | TR: A treatment target in HF?
Marianna Adamo (Italy) - 10.45-10.55 | Treating aortic stenosis in HFrEF: When is it too late or too early?
Bahira Shahim (Sweden) - 10.55-11.05 | Where do we stand for the treatment of FMR?
Marco Metra (Italy) - 11.05-11.15 | What do the new ESC guidelines say?
Marianna Adamo (Italy) - 11.15-11.45 | Round Table: Ask the experts
All
- 11.45-1200 | Lecture 2: The evolving epidemiology of HF – what does PORTHOS study teach us?
Chair: Riccardo M. Inciardi (Italy), Speaker: Cristina Gavina (Portugal)
12.00-13.00
Lunch
DAY 2 (afternoon) – 16 December 2025
- 13.00-13.25 | Lecture 3: What can AI do for our HF patients?
Chair: Mitja Lainscak (Slovenia), Speaker: Alicia Uijl (The Netherlands)
Session 6: Recognizing advanced heart failure: The right timing and the right patients to refer
13.25-14.40
Chairs: Oscar Braun (Sweden), Ovidiu Chioncel (Romania) & Michael Melin (Sweden)
Discussant: Lars H. Lund (Sweden)
- 13.25-13.40 | How to manage GDMT in advanced HF
Federica Guidetti (Sweden) - 13.40-13.55 | Diuretic resistance in advanced HF: Prevention, recognition, and treatment strategies
Wilfried Mullens (Belgium) - 13.55-14.10 | Selecting the right candidates for transplant, LVAD, or palliative care
Benedikt Schrage (Germany) - 14.10-14.40 | Round Table: Ask the experts
All
Session 7: Hypertrophic cardiomyopathy
14.40-15.30
Chairs: Mitja Lainscak (Slovenia) & Shelley Zieroth (Canada)
- 14.40-14.55 | HCM uncovered: From population patterns to precision diagnosis
Antonio Cannata (United Kingdom) - 14.55-15.10 | Treating HCM yesterday, today, and tomorrow
Christian Schulze (Germany) - 15.10-15.30 | Round Table: Ask the experts
All
- 15.30-16.00 | Lecture 4: Hot off the press and upcoming evidence
Chair: Gianluigi Savarese (Sweden), Speaker: Biykem Bozkurt (USA)
- 16.00-16.05 | Closure of the day
Gianluigi Savarese (Sweden)